Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intrahepatic Cholangiocarcinoma.

Literature DB >> 33328703

Intrahepatic Cholangiocarcinoma.

Abstract

Cholangiocarcinoma is the second most common primary malignancy of the liver. This review will focus on the mass-forming intrahepatic type of this disease and discuss the role of medical, surgical, and radiation oncology in managing this difficult disease. A global understanding to the management of intrahepatic cholangiocarcinoma (ICC) can help the interventional radiologist understand the role of locoregional therapies such as ablation, transarterial chemoembolization, and radioembolization in the management of ICC. Thieme. All rights reserved.

Entities: Disease

Keywords: ablation; cholangiocarcinoma; intrahepatic cholangiocarcinoma; mass-forming; radioembolization

Year: 2020 PMID： 33328703 PMCID： PMC7732564 DOI： 10.1055/s-0040-1719188

Source DB: PubMed Journal: Semin Intervent Radiol ISSN： 0739-9529 Impact factor: 1.513

104 in total

Review 1. Staging of intrahepatic cholangiocarcinoma.

Authors: Hari Nathan; Timothy M Pawlik
Journal: Curr Opin Gastroenterol Date: 2010-05 Impact factor: 3.287

2. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group.

Authors: Olivier Farges; David Fuks; Yves-Patrice Le Treut; Daniel Azoulay; Alexis Laurent; Philippe Bachellier; Gennaro Nuzzo; Jacques Belghiti; François René Pruvot; Jean Marc Regimbeau
Journal: Cancer Date: 2010-11-29 Impact factor: 6.860

3. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.

Authors: John Bridgewater; Peter R Galle; Shahid A Khan; Josep M Llovet; Joong-Won Park; Tushar Patel; Timothy M Pawlik; Gregory J Gores
Journal: J Hepatol Date: 2014-03-27 Impact factor: 25.083

4. Risk factors for liver abscess formation after hepatic chemoembolization.

Authors: W Kim; T W Clark; R A Baum; M C Soulen
Journal: J Vasc Interv Radiol Date: 2001-08 Impact factor: 3.464

5. Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Analysis.

Authors: Stefan Buettner; Arthur J A T Braat; Georgios Antonios Margonis; Daniel B Brown; Kevin B Taylor; Anthony J Borgmann; S Cheenu Kappadath; Armeen Mahvash; Jan N M IJzermans; Matthew J Weiss; Angela Lamarca; Jon K Bell; Juan W Valle; Jeroen Hagendoorn; Bas Groot Koerkamp; Daniel Y Sze; Marnix G E H Lam
Journal: J Vasc Interv Radiol Date: 2020-05-28 Impact factor: 3.464

6. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy.

Authors: Yizhou Wang; Jun Li; Yong Xia; Renyan Gong; Kui Wang; Zhenlin Yan; Xuying Wan; Guanghua Liu; Dong Wu; Lehua Shi; Wanyee Lau; Mengchao Wu; Feng Shen
Journal: J Clin Oncol Date: 2013-01-28 Impact factor: 44.544

7. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.

Authors: M Ohtsuka; H Ito; F Kimura; H Shimizu; A Togawa; H Yoshidome; M Miyazaki
Journal: Br J Surg Date: 2002-12 Impact factor: 6.939

Review 8. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.

Authors: Lucas M Boehm; Thejus T Jayakrishnan; John T Miura; Anthony J Zacharias; Fabian M Johnston; Kiran K Turaga; T Clark Gamblin
Journal: J Surg Oncol Date: 2014-09-01 Impact factor: 3.454

9. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma.

Authors: Yoshikazu Morimoto; Yasuhiro Tanaka; Toshinori Ito; Masaaki Nakahara; Hiroyuki Nakaba; Toshiro Nishida; Masahiro Fujikawa; Toshikazu Ito; Shigetaka Yamamoto; Toru Kitagawa
Journal: J Hepatobiliary Pancreat Surg Date: 2003

10. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.

Authors: Randa Tao; Sunil Krishnan; Priya R Bhosale; Milind M Javle; Thomas A Aloia; Rachna T Shroff; Ahmed O Kaseb; Andrew J Bishop; Cameron W Swanick; Eugene J Koay; Howard D Thames; Theodore S Hong; Prajnan Das; Christopher H Crane
Journal: J Clin Oncol Date: 2015-10-26 Impact factor: 44.544

1 in total

Review 1. ARID1A Variations in Cholangiocarcinoma: Clinical Significances and Molecular Mechanisms.

Authors: Shankun Zhao; Youwen Xu; Weizhou Wu; Pan Wang; Yichao Wang; Hao Jiang; Jie Zhu
Journal: Front Oncol Date: 2021-06-25 Impact factor: 6.244

1 in total